Transmitted HIV type 1 drug resistance among individuals with recent HIV infection in East and Southern Africa
MA Price, CL Wallis, S Lakhi, E Karita… - AIDS research and …, 2011 - liebertpub.com
To characterize WHO-defined transmitted HIV drug resistance mutation (TDRM) data from
recently HIV-infected African volunteers, we sequenced HIV (pol) and evaluated for TDRM …
recently HIV-infected African volunteers, we sequenced HIV (pol) and evaluated for TDRM …
HIV-1 antiretroviral drug resistance mutations in treatment naïve and experienced Panamanian subjects: impact on national use of EFV-based schemes
The use of antiretroviral therapy in HIV infected subjects prevents AIDS-related illness and
delayed occurrence of death. In Panama, rollout of ART started in 1999 and national …
delayed occurrence of death. In Panama, rollout of ART started in 1999 and national …
Sensitive testing of plasma HIV-1 RNA and Sanger sequencing of cellular HIV-1 DNA for the detection of drug resistance prior to starting first-line antiretroviral therapy …
AM Geretti, T Conibear, A Hill… - Journal of …, 2014 - academic.oup.com
Objectives This study investigated strategies that may increase the yield of drug resistance
testing prior to starting antiretroviral therapy (ART), and whether transmitted and …
testing prior to starting antiretroviral therapy (ART), and whether transmitted and …
Trends in the molecular epidemiology and genetic mechanisms of transmitted human immunodeficiency virus type 1 drug resistance in a large US clinic population
SY Rhee, D Clutter, WJ Fessel, D Klein… - Clinical Infectious …, 2019 - academic.oup.com
Background There are few large studies of transmitted drug resistance (TDR) prevalence
and the drug resistance mutations (DRMs) responsible for TDR in the United States …
and the drug resistance mutations (DRMs) responsible for TDR in the United States …
Reliability and clinical relevance of the HIV-1 drug resistance test in patients with low viremia levels
Background. We evaluated reliability and clinical usefulness of genotypic resistance testing
(GRT) in patients for whom combination antiretroviral therapy (cART) was unsuccessful with …
(GRT) in patients for whom combination antiretroviral therapy (cART) was unsuccessful with …
Emergence of acquired HIV-1 drug resistance almost stopped in Switzerland: a 15-year prospective cohort analysis
AU Scherrer, V Von Wyl, WL Yang… - Clinical infectious …, 2016 - academic.oup.com
Background. Drug resistance is a major barrier to successful antiretroviral treatment (ART).
Therefore, it is important to monitor time trends at a population level. Methods. We included …
Therefore, it is important to monitor time trends at a population level. Methods. We included …
Long-term trends of HIV type 1 drug resistance prevalence among antiretroviral treatment–experienced patients in Switzerland
V von Wyl, S Yerly, J Böni, P Bürgisser… - Clinical Infectious …, 2009 - academic.oup.com
Background. Accurate quantification of the prevalence of human immunodeficiency virus
type 1 (HIV-1) drug resistance in patients who are receiving antiretroviral therapy (ART) is …
type 1 (HIV-1) drug resistance in patients who are receiving antiretroviral therapy (ART) is …
Characterizing the emergence and persistence of drug resistant mutations in HIV-1 subtype C infections using 454 ultra deep pyrosequencing
V Bansode, GP McCormack, AC Crampin… - BMC infectious …, 2013 - Springer
Background The role of HIV-1 RNA in the emergence of resistance to antiretroviral therapies
(ARTs) is well documented while less is known about the role of historical viruses stored in …
(ARTs) is well documented while less is known about the role of historical viruses stored in …
Prevalence of transmitted drug resistance associated mutations and HIV-1 subtypes in new HIV-1 diagnoses, US–2006
WH Wheeler, RA Ziebell, H Zabina, D Pieniazek… - Aids, 2010 - journals.lww.com
Objective: To determine the distribution of HIV-1 subtypes and the prevalence of transmitted
drug resistance-associated mutations (TDRM) among persons newly diagnosed with HIV-1 …
drug resistance-associated mutations (TDRM) among persons newly diagnosed with HIV-1 …
National sentinel surveillance of transmitted drug resistance in antiretroviral-naive chronically HIV-infected patients in France over a decade: 2001–2011
D Descamps, L Assoumou, ML Chaix… - Journal of …, 2013 - academic.oup.com
Objectives As recommended by the French ANRS programme for the surveillance of HIV-1
resistance, we estimated the prevalence of transmitted drug resistance-associated mutations …
resistance, we estimated the prevalence of transmitted drug resistance-associated mutations …